These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 312690)

  • 21. Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma: pre-surgical treatment of primary tumor and of overt pulmonary metastases.
    Jaffe N; Frei E; Traggis D; Watts H
    Cancer; 1977 Jan; 39(1):45-50. PubMed ID: 299828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
    J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
    Kickinger W; Ritschl P; Kotz R
    Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High dose methotrexate with citrovorum factor rescue therapy. (2) Measurement of methotrexate and its major metabolite, 7-hydroxymethotrexate in cerebrospinal fluid by high pressure liquid chromatography].
    Tanaka J; Kinpara H; Sasaki K; Fujimoto T
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):889-95. PubMed ID: 6604768
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Am J Obstet Gynecol; 1985 May; 152(1):59-62. PubMed ID: 2986458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia.
    Christensen ML; Rivera GK; Crom WR; Hancock ML; Evans WE
    J Clin Oncol; 1988 May; 6(5):797-801. PubMed ID: 3163362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential combination chemotherapy of advanced head and neck carcinoma: re-evaluation of a highly effective regimen.
    Veronesi A; Barzan L; Magri MD; Tirelli U; Galligioni E; Trovò MG; Tumolo S; Comoretto R; Grigoletto E
    Strahlentherapie; 1981 Apr; 157(4):277-9. PubMed ID: 6166105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
    Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
    Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Limitations of methotrexate and citrovorum-factor treatment.
    Frei E; Jaffe NJ; Pitman S
    N Engl J Med; 1975 Jan; 292(2):107-8. PubMed ID: 1078551
    [No Abstract]   [Full Text] [Related]  

  • 30. The pharmacology and clinical use of methotrexate.
    Jolivet J; Cowan KH; Curt GA; Clendeninn NJ; Chabner BA
    N Engl J Med; 1983 Nov; 309(18):1094-104. PubMed ID: 6353235
    [No Abstract]   [Full Text] [Related]  

  • 31. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
    Barlow JJ; Piver MS
    Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
    Levi M; Sulkes A; Katz E; Rizel S; Biran S
    Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
    [No Abstract]   [Full Text] [Related]  

  • 34. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
    Kremer WB; Vogler WR; Chan YK
    Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
    Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of oral methotrexate (mtx) in the treatment of tumours in the head and neck-region.
    Rietberg M
    Arch Chir Neerl; 1970; 22(2):107-16. PubMed ID: 4317753
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.
    Mitchell MS; Wawro NW; DeConti RC; Kaplan SR; Papac R; Bertino JR
    Cancer Res; 1968 Jun; 28(6):1088-94. PubMed ID: 4298056
    [No Abstract]   [Full Text] [Related]  

  • 38. Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
    Sadée W
    Ther Drug Monit; 1980; 2(2):177-85. PubMed ID: 6762711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission induction of meningeal leukemia with high-dose intravenous methotrexate.
    Balis FM; Savitch JL; Bleyer WA; Reaman GH; Poplack DG
    J Clin Oncol; 1985 Apr; 3(4):485-9. PubMed ID: 3856631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of 24-hour infusion of high-dose methotrexate--pharmacokinetics and toxicity.
    Goh TS; Wong KY; Lampkin B; O'Leary J; Gnarra D
    Cancer Chemother Pharmacol; 1979; 3(3):177-80. PubMed ID: 316745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.